These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34109363)

  • 1. [Study of salivary metabonomics in patients with oral squamous cell carcinoma and leukoplakia].
    Xue JY; Zhu XY; Wei CL; Sun P; Zhang H; Deng J
    Shanghai Kou Qiang Yi Xue; 2021 Apr; 30(2):201-205. PubMed ID: 34109363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
    Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
    Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compositional and functional changes in the salivary microbiota related to oral leukoplakia and oral squamous cell carcinoma: a case control study.
    Lan Q; Zhang C; Hua H; Hu X
    BMC Oral Health; 2023 Dec; 23(1):1021. PubMed ID: 38115005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in oral microbial profiles associated with oral squamous cell carcinoma vs leukoplakia.
    Hashimoto K; Shimizu D; Hirabayashi S; Ueda S; Miyabe S; Oh-Iwa I; Nagao T; Shimozato K; Nomoto S
    J Investig Clin Dent; 2019 Nov; 10(4):e12445. PubMed ID: 31342659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia.
    Yan SK; Wei BJ; Lin ZY; Yang Y; Zhou ZT; Zhang WD
    Oral Oncol; 2008 May; 44(5):477-83. PubMed ID: 17936673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expressions of Interleukin-27 in Oral Lichen Planus, Oral Leukoplakia, and Oral Squamous Cell Carcinoma.
    Wang QM; Huang XY; Guan WQ
    Inflammation; 2022 Jun; 45(3):1023-1038. PubMed ID: 35064378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary metabolite signatures of oral cancer and leukoplakia.
    Wei J; Xie G; Zhou Z; Shi P; Qiu Y; Zheng X; Chen T; Su M; Zhao A; Jia W
    Int J Cancer; 2011 Nov; 129(9):2207-17. PubMed ID: 21190195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ADAM10 in oral squamous cell carcinoma with metastases.
    Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Kulicka P; Danilewicz M
    Pol J Pathol; 2018; 69(1):67-72. PubMed ID: 29895129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma.
    Sridharan G; Ramani P; Patankar S; Vijayaraghavan R
    J Oral Pathol Med; 2019 Apr; 48(4):299-306. PubMed ID: 30714209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
    Xu SB; Wang MY; Shi XZ; Wang Q; Yu M; Zhang W; Xu XH; Liu LK
    Oral Dis; 2023 Nov; 29(8):3268-3277. PubMed ID: 35921211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of serum biomarkers and evaluation of metabolism disorders in patients with oral squamous cell carcinoma].
    Li XB; Liu LW; Li N; Jia QQ; Wang XS; Long JL; Xue P; Sun Z; Zhao HY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Sep; 56(9):926-932. PubMed ID: 34496544
    [No Abstract]   [Full Text] [Related]  

  • 12. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    G D; Nandan SRK; Kulkarni PG
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
    Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
    J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Ki-67, Cyclin D1, P53, and P16 in patients with oral leukoplakia and leukoplakia cancerization with spicy diet in Chengdu.
    Wan ZX; Zheng ZJ; Huang MC; Chen Y; Yao LH
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Aug; 39(4):434-440. PubMed ID: 34409799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia.
    Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T
    J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
    Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
    Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
    Cao J; Jin JQ; Deng DJ; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative analysis of methylation profiles in tissues of oral leukoplakia and oral squamous cell carcinoma].
    Fu J; Su Y; Liu Y; Zhang XY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Apr; 53(4):248-253. PubMed ID: 29690695
    [No Abstract]   [Full Text] [Related]  

  • 19. DEC1: a potential biomarker of malignant transformation in oral leukoplakia.
    Mao T; Xiong H; Hu X; Hu Y; Wang C; Yang L; Huang D; Xia K; Su T
    Braz Oral Res; 2020; 34():e052. PubMed ID: 32578762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma.
    Sridharan G; Ramani P; Patankar S
    J Cancer Res Ther; 2017; 13(3):556-561. PubMed ID: 28862226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.